Stephen Maxted Ansell, MD, PhD

  • 22276 Citations
  • 80 Scopus h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2016
27 Scopus citations

Expression of CD14+ HLA-DRlow/- monocytes in peripheral blood of patients with non-Hodgkin lymphoma and its significance

Xiu, B., Qiu, Y., Zheng, W. P., Wang, X. Q., Ding, Y., Li, P., Chen, Y. H., Wu, H., Zhang, W. J., Liang, A. B., Yang, Z. Z. & Ansell, S. M., Nov 25 2016, In : Journal of Leukemia and Lymphoma. 25, 11, p. 645-650 6 p.

Research output: Contribution to journalArticle

FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: A meta-analysis on 1134 patients from two prospective cohorts

Ghesquières, H., Larrabee, B. R., Haioun, C., Link, B. K., Verney, A., Slager, S. L., Ketterer, N., Ansell, S. M., Delarue, R., Maurer, M. J., Fitoussi, O., Habermann, T. M., Peyrade, F., Dogan, A., Molina, T. J., Novak, A. J., Tilly, H., Cerhan, J. R. & Salles, G., 2016, (Accepted/In press) In : Hematological Oncology.

Research output: Contribution to journalArticle

2 Scopus citations

Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma

Chen, R., Gopal, A. K., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Connors, J. M., Engert, A., Larsen, E. K., Huebner, D., Fong, A. & Younes, A., Sep 22 2016, In : Blood. 128, 12, p. 1562-1566 5 p.

Research output: Contribution to journalArticle

154 Scopus citations

Follicular lymphoma tregs have a distinct transcription profile impacting their migration and retention in the malignant lymph node

Nedelkovska, H., Rosenberg, A. F., Hilchey, S. P., Hyrien, O., Burack, W. R., Quataert, S. A., Baker, C. M., Azadniv, M., Welle, S. L., Ansell, S. M., Kim, M. & Bernstein, S. H., May 1 2016, In : PLoS One. 11, 5, e0155347.

Research output: Contribution to journalArticle

8 Scopus citations

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

Machiela, M. J., Lan, Q., Slager, S. L., Vermeulen, R. C. H., Teras, L. R., Camp, N. J., Cerhan, J. R., Spinelli, J. J., Wang, S. S., Nieters, A., Vijai, J., Yeager, M., Wang, Z., Ghesquières, H., McKay, J., Conde, L., de Bakker, P. I. W., Cox, D. G., Burdett, L., Monnereau, A. & 100 others, Flowers, C. R., De Roos, A. J., Brooks-Wilson, A. R., Giles, G. G., Melbye, M., Gu, J., Jackson, R. D., Kane, E., Purdue, M. P., Vajdic, C. M., Albanes, D., Kelly, R. S., Zucca, M., Bertrand, K. A., Zeleniuch-Jacquotte, A., Lawrence, C., Hutchinson, A., Zhi, D., Habermann, T. M., Link, B. K., Novak, A. J., Dogan, A., Asmann, Y., Liebow, M., Thompson, C. A., Ansell, S. M., Witzig, T. E., Tilly, H., Haioun, C., Molina, T. J., Hjalgrim, H., Glimelius, B., Adami, H. O., Roos, G., Bracci, P. M., Riby, J., Smith, M. T., Holly, E. A., Cozen, W., Hartge, P., Morton, L. M., Severson, R. K., Tinker, L. F., North, K. E., Becker, N., Benavente, Y., Boffetta, P., Brennan, P., Foretova, L., Maynadie, M., Staines, A., Lightfoot, T., Crouch, S., Smith, A., Roman, E., Ryan Diver, W., Offit, K., Zelenetz, A., Klein, R. J., Villano, D. J., Zheng, T., Zhang, Y., Holford, T. R., Turner, J., Southey, M. C., Clavel, J., Virtamo, J., Weinstein, S., Riboli, E., Vineis, P., Kaaks, R., Boeing, H., Tjønneland, A., Angelucci, E., Di Lollo, S., Rais, M., De Vivo, I., Giovannucci, E., Kraft, P., Huang, J., Ma, B., Ye, Y., Chiu, B. C. H., Liang, L., Park, J. H., Chung, C. C., Weisenburger, D. D., Fraumeni, J. F., Salles, G., Glenn, M., Cannon-Albright, L., Curtin, K., Wu, X., Smedby, K. E., de Sanjose, S., Skibola, C. F., Berndt, S. I., Birmann, B. M., Chanock, S. J. & Rothman, N., Apr 15 2016, In : Human Molecular Genetics. 25, 8, p. 1663-1676 14 p., ddw027.

Research output: Contribution to journalArticle

29 Scopus citations

Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphoma*

Villasboas Bisneto, J. J. C. . & Ansell, S. M., Oct 28 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-3 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond

Ansell, S. M., Jan 1 2016, In : American Journal of Hematology. 91, 1, p. 109-112 4 p.

Research output: Contribution to journalArticle

10 Scopus citations

Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management

Ansell, S. M., Apr 1 2016, In : American Journal of Hematology. 91, 4, p. 434-442 9 p.

Research output: Contribution to journalArticle

52 Scopus citations

How to select the frontline treatment for a patient with peripheral T-cell lymphoma

Ansell, S. M., Apr 2 2016, In : Leukemia and Lymphoma. 57, 4, p. 783-788 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Houot, R., Gaulard, P., Schreiber, R., Mellman, I., Lambotte, O., Coulie, P. G., Fest, T., Korman, A., Levy, R., Shipp, M., Tarte, K., Kohrt, H., Marabelle, A., Ansell, S. M., Watier, H., van Elsas, A., Balakumaran, A., Arce Vargas, F., Quezada, S. A., Salles, G. & 1 others, Olive, D., Jul 2 2016, In : OncoImmunology. 5, 7, e1186323.

Research output: Contribution to journalArticle

2 Scopus citations

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma

Luchtel, R., Razidlo, G., Dasari, S., Zeng, Y., Hu, G., Knudson, R. A., Greipp, P. T., Davila, J. I., Johnson, S. H., Porcher, J. C., Smadbeck, J., Eckloff, B. W., Billadeau, D. D., Kurtin, P. J., Mc Niven, M. A., Link, B. K., Ansell, S. M., Cerhan, J. R., Asmann, Y., Vasmatzis, G. & 1 others, Feldman, A. L., Sep 1 2016, In : Blood. 128, 9, p. 1234-1245 12 p.

Research output: Contribution to journalArticle

47 Scopus citations

Large b-cell transformation in nodular lymphocyte-predominant hodgkin lymphoma: 40-year experience from a single institution

Kenderian, S., Habermann, T. M., Macon, W. R., Ristow, K. M., Ansell, S. M., Colgan, J. P., Johnston, P. B., Inwards, D. J., Markovic, S. N., Micallef, I., Thompson, C. A., Porrata, L. F., Martenson, J. A., Witzig, T. E. & Nowakowski, G. S., Apr 21 2016, In : Blood. 127, 16, p. 1960-1966 7 p.

Research output: Contribution to journalArticle

22 Scopus citations

Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations

King, R., Gonsalves, W., Ansell, S. M., Greipp, P. T., Frederick, L. A., Viswanatha, D. S., He, R., Kyle, R. A., Gertz, M., Kapoor, P., Morice, W. G. & Howard, M. T., Jun 1 2016, In : American Journal of Clinical Pathology. 145, 6, p. 843-851 9 p.

Research output: Contribution to journalArticle

20 Scopus citations

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

Younes, A., Santoro, A., Shipp, M., Zinzani, P. L., Timmerman, J. M., Ansell, S. M., Armand, P., Fanale, M., Ratanatharathorn, V., Kuruvilla, J., Cohen, J. B., Collins, G., Savage, K. J., Trneny, M., Kato, K., Farsaci, B., Parker, S. M., Rodig, S., Roemer, M. G. M., Ligon, A. H. & 1 others, Engert, A., Sep 1 2016, In : The Lancet Oncology. 17, 9, p. 1283-1294 12 p.

Research output: Contribution to journalArticle

403 Scopus citations
11 Scopus citations

Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study

Lesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., Dhodapkar, M., Avigan, D., Chapuy, B., Ligon, A. H., Freeman, G. J., Rodig, S. J., Cattry, D., Zhu, L., Grosso, J. F., Brigid Bradley Garelik, M. & 3 others, Shipp, M. A., Borrello, I. & Timmerman, J., Aug 10 2016, In : Journal of Clinical Oncology. 34, 23, p. 2698-2704 7 p.

Research output: Contribution to journalArticle

394 Scopus citations

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma

Maurer, M. J., Jais, J. P., Ghesquières, H., Witzig, T. E., Hong, F., Haioun, C., Thompson, C. A., Thieblemont, C., Micallef, I., Porrata, L. F., Ribrag, V., Nowakowski, G. S., Casasnovas, O., Bologna, S., Morschhauser, F., Morrison, V. A., Peterson, B. A., Macon, W. R., Copie-Bergman, C., Feldman, A. L. & 13 others, Syrbu, S. I., Kurtin, P. J., Gascoyne, R. D., Li, H., Allmer, C., Kahl, B. S., Ansell, S. M., Slager, S. L., Link, B. K., Salles, G., Habermann, T. M., Tilly, H. & Cerhan, J. R., Feb 1 2016, In : American Journal of Hematology. 91, 2, p. 179-184 6 p.

Research output: Contribution to journalArticle

18 Scopus citations

Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy

Cheson, B. D., Ansell, S. M., Schwartz, L., Gordon, L. I., Advani, R., Jacene, H. A., Hoos, A., Barrington, S. F. & Armand, P., Nov 24 2016, In : Blood. 128, 21, p. 2489-2496 8 p.

Research output: Contribution to journalArticle

115 Scopus citations

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

Fowler, N. H., Cheah, C. Y., Gascoyne, R. D., Gribben, J., Neelapu, S. S., Ghia, P., Bollard, C., Ansell, S. M., Curran, M., Wilson, W. H., O’Brien, S., Grant, C., Little, R., Zenz, T., Nastoupil, L. J. & Dunleavy, K., Apr 30 2016, In : Haematologica. 101, 5, p. 531-540 10 p.

Research output: Contribution to journalArticle

21 Scopus citations
42 Scopus citations

The landscape of new drugs in lymphoma

Younes, A., Ansell, S. M., Fowler, N., Wilson, W., de Vos, S., Seymour, J., Advani, R., Forero, A., Morschhauser, F., Kersten, M. J., Tobinai, K., Zinzani, P. L., Zucca, E., Abramson, J. & Vose, J., Dec 29 2016, (Accepted/In press) In : Nature Reviews Clinical Oncology.

Research output: Contribution to journalArticle

32 Scopus citations

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia

Boyiadzis, M., Bishop, M. R., Abonour, R., Anderson, K. C., Ansell, S. M., Avigan, D., Barbarotta, L., Barrett, A. J., Besien, K., Bergsagel, P. L., Borrello, I., Brody, J., Brufsky, J., Cairo, M., Chari, A., Cohen, A., Cortes, J., Forman, S. J., Friedberg, J. W., Fuchs, E. J. & 28 others, Gore, S. D., Jagannath, S., Kahl, B. S., Kline, J., Kochenderfer, J. N., Kwak, L. W., Levy, R., Lima, M., Litzow, M. R., Mahindra, A., Miller, J., Munshi, N. C., Orlowski, R. Z., Pagel, J. M., Porter, D. L., Russell, S. J., Schwartz, K., Shipp, M. A., Siegel, D., Stone, R. M., Tallman, M. S., Timmerman, J. M., Rhee, F., Waller, E. K., Welsh, A., Werner, M., Wiernik, P. H. & Dhodapkar, M. V., Dec 20 2016, In : Journal for ImmunoTherapy of Cancer. 4, 1, 90.

Research output: Contribution to journalArticle

6 Scopus citations

Treatment of HIV/AIDS associated cancers with immunotherapy targeting PD-1/PD-L1 instead of chemotherapy

Kasi, P. M., Block, M. S. & Ansell, S. M., Jan 1 2016, In : Medical Hypotheses. 86, p. 129-131 3 p.

Research output: Contribution to journalArticle

6 Scopus citations

Where do programmed death-1 inhibitors fit in the management of malignant lymphoma?

Ansell, S. M., Feb 1 2016, In : Journal of Oncology Practice. 12, 2, p. 101-106 6 p.

Research output: Contribution to journalArticle

8 Scopus citations
2015

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

Vijai, J., Wang, Z., Berndt, S. I., Skibola, C. F., Slager, S. L., De Sanjose, S., Melbye, M., Glimelius, B., Bracci, P. M., Conde, L., Birmann, B. M., Wang, S. S., Brooks-Wilson, A. R., Lan, Q., De Bakker, P. I. W., Vermeulen, R. C. H., Portlock, C., Ansell, S. M., Link, B. K., Riby, J. & 82 others, North, K. E., Gu, J., Hjalgrim, H., Cozen, W., Becker, N., Teras, L. R., Spinelli, J. J., Turner, J., Zhang, Y., Purdue, M. P., Giles, G. G., Kelly, R. S., Zeleniuch-Jacquotte, A., Ennas, M. G., Monnereau, A., Bertrand, K. A., Albanes, D., Lightfoot, T., Yeager, M., Chung, C. C., Burdett, L., Hutchinson, A., Lawrence, C., Montalvan, R., Liang, L., Huang, J., Ma, B., Villano, D. J., Maria, A., Corines, M., Thomas, T., Novak, A. J., Dogan, A., Liebow, M., Thompson, C. A., Witzig, T. E., Habermann, T. M., Weiner, G. J., Smith, M. T., Holly, E. A., Jackson, R. D., Tinker, L. F., Ye, Y., Adami, H. O., Smedby, K. E., De Roos, A. J., Hartge, P., Morton, L. M., Severson, R. K., Benavente, Y., Boffetta, P., Brennan, P., Foretova, L., Maynadie, M., McKay, J., Staines, A., DIver, W. R., Vajdic, C. M., Armstrong, B. K., Kricker, A., Zheng, T., Holford, T. R., Severi, G., Vineis, P., Ferri, G. M., Ricco, R., Miligi, L., Clavel, J., Giovannucci, E., Kraft, P., Virtamo, J., Smith, A., Kane, E., Roman, E., Chiu, B. C. H., Fraumeni, J. F., Wu, X., Cerhan, J. R., Offit, K., Chanock, S. J., Rothman, N. & Nieters, A., Jan 8 2015, In : Nature Communications. 6, 6751.

Research output: Contribution to journalArticle

30 Scopus citations

Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: A randomized, double-blind, placebo-controlled phase 2b trial

Fayad, L., Ansell, S. M., Advani, R., Coiffier, B., Stuart, R., Bartlett, N. L., Forero-Torres, A., Kuliczkowski, K., Belada, D., Ng, E. & Drachman, J. G., Sep 2 2015, In : Leukemia and Lymphoma. 56, 9, p. 2569-2578 10 p.

Research output: Contribution to journalArticle

13 Scopus citations

Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

Gopal, A. K., Chen, R., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Connors, J. M., Engert, A., Larsen, E. K., Chi, X., Sievers, E. L. & Younes, A., Feb 19 2015, In : Blood. 125, 8, p. 1236-1243 8 p.

Research output: Contribution to journalArticle

135 Scopus citations

Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates

Zent, C. S., Call, T. G., Bowen, D. A., Conte, M. J., LaPlant, B. R., Witzig, T. E., Ansell, S. M. & Weiner, G. J., Aug 3 2015, In : Leukemia and Lymphoma. 56, 8, p. 2373-2378 6 p.

Research output: Contribution to journalArticle

12 Scopus citations

Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma

Mir, M. A., Maurer, M. J., Ziesmer, S. C., Slager, S. L., Habermann, T., Macon, W. R., Link, B. K., Syrbu, S., Witzig, T., Friedberg, J. W., Press, O., LeBlanc, M., Cerhan, J. R., Novak, A. & Ansell, S. M., Feb 5 2015, In : Blood. 125, 6, p. 992-998 7 p.

Research output: Contribution to journalArticle

22 Scopus citations

Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

Chakraborty, R., Kapoor, P., Ansell, S. M. & Gertz, M., Oct 3 2015, In : Expert Review of Anticancer Therapy. 15, 10, p. 1143-1156 14 p.

Research output: Contribution to journalArticle

4 Scopus citations

Expression of the chemokine receptor gene, CCR8, is associated with DUSP22 rearrangements in anaplastic large cell lymphoma

Xing, X., Flotte, T. J., Law, M. E., Blahnik, A. J., Chng, W. J., Huang, G., Knudson, R. A., Ketterling, R. P., Porcher, J. C., Ansell, S. M., Sidhu, J., Dogan, A. & Feldman, A. L., Sep 23 2015, In : Applied Immunohistochemistry and Molecular Morphology. 23, 8, p. 580-589 10 p.

Research output: Contribution to journalArticle

4 Scopus citations

Genome-Wide association study of event-free survival in diffuse large B-cell lymphoma treated with immunochemotherapy

Ghesquieres, H., Slager, S. L., Jardin, F., Veron, A. S., Asmann, Y., Maurer, M. J., Fest, T., Habermann, T. M., Bene, M. C., Novak, A. J., Mareschal, S., Haioun, C., Lamy, T., Ansell, S. M., Tilly, H., Witzig, T. E., Weiner, G. J., Feldman, A. L., Dogan, A., Cunningham, J. M. & 7 others, Olswold, C. L., Molina, T. J., Link, B. K., Milpied, N., Cox, D. G., Salles, G. A. & Cerhan, J. R., Nov 20 2015, In : Journal of Clinical Oncology. 33, 33, p. 3930-3937 8 p.

Research output: Contribution to journalArticle

11 Scopus citations

Hodgkin lymphoma: Diagnosis and treatment

Ansell, S. M., 2015, In : Mayo Clinic Proceedings. 90, 11, p. 1574-1583 10 p.

Research output: Contribution to journalArticle

50 Scopus citations

Ibrutinib for the treatment of Waldenström macroglobulinemia

Chakraborty, R., Kapoor, P., Ansell, S. M. & Gertz, M., Sep 3 2015, In : Expert Review of Hematology. 8, 5, p. 569-579 11 p.

Research output: Contribution to journalArticle

10 Scopus citations

IL-10 induces the development of immunosuppressive CD14+ HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma

Xiu, B., Lin, Y., Grote, D. M., Ziesmer, S. C., Gustafson, M., Maas, M. L., Zhang, Z., Dietz, A. B., Porrata, L. F., Novak, A. J., Liang, A. B., Yang, Z. Z. & Ansell, S. M., Jul 31 2015, In : Blood Cancer Journal. 5, 7, e328.

Research output: Contribution to journalArticle

33 Scopus citations

Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma

Porrata, L. F., Burgstaler, E. A., Winters, J. L., Jacob, E. K., Gastineau, D. A., Suman, V. J., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Nevala, W. & Markovic, S. N., Sep 23 2015, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

7 Scopus citations
3 Scopus citations

Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Hogan, W. & Markovic, S. N., Feb 2 2015, In : Journal of Blood Medicine. 6, p. 45-53 9 p.

Research output: Contribution to journalArticle

7 Scopus citations
205 Scopus citations

Non-Hodgkin Lymphoma: Diagnosis and Treatment

Ansell, S. M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1152-1163 12 p.

Research output: Contribution to journalArticle

32 Scopus citations

Non-Hodgkin lymphoma, body mass index, and cytokine polymorphisms: A pooled analysis from the interlymph consortium

Kane, E., Skibola, C. F., Bracci, P. M., Cerhan, J. R., Costas, L., Smedby, K. E., Holly, E. A., Maynadié, M., Novak, A. J., Lightfoot, T. J., Ansell, S. M., Smith, A. G., Liebow, M., Melbye, M., Morton, L., De Sanjosé, S., Slager, S. L., Wang, S. S., Zhang, Y., Zheng, T. & 1 others, Roman, E., Jul 1 2015, In : Cancer Epidemiology Biomarkers and Prevention. 24, 7, p. 1061-1070 10 p.

Research output: Contribution to journalArticle

4 Scopus citations
1 Scopus citations

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., Schuster, S. J., Millenson, M. M., Cattry, D., Freeman, G. J., Rodig, S. J., Chapuy, B., Ligon, A. H., Zhu, L., Grosso, J. F., Kim, S. Y., Timmerman, J. M., Shipp, M. A. & Armand, P., Jan 22 2015, In : New England Journal of Medicine. 372, 4, p. 311-319 9 p.

Research output: Contribution to journalArticle

1820 Scopus citations

PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival

Yang, Z. Z., Grote, D. M., Ziesmer, S. C., Xiu, B., Novak, A. J. & Ansell, S. M., Jan 1 2015, In : Blood Cancer Journal. 5, 2, e281.

Research output: Contribution to journalArticle

66 Scopus citations

Phase II clinical trials for Waldenstrom's macroglobulinemia

Chakraborty, R., Ansell, S. M., Kapoor, P. & Gertz, M., May 1 2015, In : Expert Opinion on Orphan Drugs. 3, 5, p. 537-547 11 p.

Research output: Contribution to journalArticle

Survival in patients with limited-stage peripheral T-cell lymphomas

Briski, R., Feldman, A. L., Bailey, N. G., Lim, M. S., Ristow, K., Habermann, T. M., Macon, W. R., Inwards, D. J., Colgan, J. P., Nowakowski, G. S., Kaminski, M. S., Witzig, T. E., Ansell, S. M. & Wilcox, R. A., Jun 1 2015, In : Leukemia and Lymphoma. 56, 6, p. 1665-1670 6 p.

Research output: Contribution to journalArticle

12 Scopus citations
29 Scopus citations

Targeting immune checkpoints in lymphoma

Ansell, S. M., Jul 1 2015, In : Current Opinion in Hematology. 22, 4, p. 337-342 6 p.

Research output: Contribution to journalArticle

29 Scopus citations